1
|
Li M, Wang F, Tao M, Zhang Y, Pan R, Gu D, Zhong H, Xu Y. N95 respirators alter facial skin physiological functions and lipidome composition in health care personnel. Skin Res Technol 2024; 30:e13653. [PMID: 38488420 PMCID: PMC10941554 DOI: 10.1111/srt.13653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 02/28/2024] [Indexed: 03/18/2024]
Abstract
BACKGROUND During the coronavirus disease 2019 pandemic, wearing medical respirators and masks was essential to prevent transmission. OBJECTIVE To quantify the effects of N95 mask usage by measuring facial skin biophysical characteristics and changes in the lipidome. METHODS Sixty healthy volunteers wore N95 respirators for 3 or 6 h. Facial images were acquired and physiological parameters were measured in specific facial areas, before and after mask-wearing. Lipidome analysis was also performed. RESULTS After N95 respirator usage, facial erythema was observed in both the 3 and 6 h groups. Both sebum secretion and trans-epidermal water loss increased significantly in mask-covered cheeks and chins after 6 h of mask wearing compared with before mask wearing (p < 0.05). Principal component analysis revealed significant differences in lipid composition after mask wearing compared with before. The ceramide subclass NS exhibited a positive correlation with stratum corneum hydration, whereas the AP subclass was negatively correlated with trans-epidermal water loss in the 6 h group. CONCLUSION Prolonged wear of N95 respirators may impair facial skin function and alter lipidome composition.
Collapse
Affiliation(s)
- Min Li
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
- Department of DermatologyFifth People's Hospital of SuzhouSuzhouChina
| | - Feifei Wang
- Yunnan Characteristic Plant Extraction LaboratoryYunnan Yunke Characteristic Plant Extraction Laboratory Co., LtdKunmingChina
- State Key Laboratory of Natural Medicines, School of Traditional Chinese PharmacyChina Pharmaceutical UniversityNanjingChina
| | - Meng Tao
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
- Department of DermatologyZigong Fourth People's HospitalZigongChina
| | - Yue Zhang
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
| | - Ruoxin Pan
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
| | - Duoduo Gu
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
| | - Hui Zhong
- State Key Laboratory of Natural Medicines, School of Traditional Chinese PharmacyChina Pharmaceutical UniversityNanjingChina
| | - Yang Xu
- Department of DermatologyThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
| |
Collapse
|
2
|
Nabatanzi A, Mafuru M, Male M, Tian C, Zhang L, Wu T, Wu S, Huang C. <p>Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet<sup>®</sup>), Viaminate and Concomitant Conventional Therapies: A Retrospective Study</p>. Clin Cosmet Investig Dermatol 2020; 13:789-794. [PMID: 33149651 PMCID: PMC7605519 DOI: 10.2147/ccid.s276148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2020] [Accepted: 09/26/2020] [Indexed: 11/23/2022]
Abstract
Background The available treatments for refractory hyperkeratotic eczema are inadequate with frustrating results. We, therefore, incorporated Calcipotriol and Betamethasone Dipropionate (Daivobet®), and Viaminate into the mainstay treatment to improve the clinical symptoms. The study aimed to evaluate the efficacy of Daivobet® and Viaminate as a potential treatment alternative for refractory hyperkeratotic eczema. Patients and Methods Between 2013 and 2015, 61 patients diagnosed with refractory hyperkeratotic eczema (RHE) who had shown inadequate response to conventional therapies were pooled from a single center. Besides, they were all treated with Daivobet®, Viaminate, and an occlusive dressing mixture containing 5% salicylic acid ointment and 25% zinc oxide paste following inadequate response to conventional therapies (corticosteroids plus 25% zinc oxide paste and 5% salicylic acid ointment). Investigators Global Assessment (IGA) and Patient-Oriented Eczema Measure (POEM) assessed baseline and outcome measures for the degree of hyperkeratinization (0-clear; 3-moderate; 4-severe). Results Of the 61 patients, 49 (80.3%) patients presented with moderate RHE and 12 (19.7%) with severe RHE. After 24 weeks of treatment, the period for loss of keratinization was significantly lower in patients with moderate RHE (3.9±1.9 weeks) than those with severe RHE (10.8±1.0 weeks) with a P-value <0.01. Furthermore, they required a significantly shorter total treatment duration (10.6 ± 4.3 weeks) than those with severe RHE (20.3±3.6 weeks) with a P-value of <0.01. However, there were no significant differences in post hoc analysis at week 36 with P-values of 0.46 and 1.00 for IGA and POEM, respectively. Conclusion Our results showed that the incorporation of Viaminate and Daivobet® into mainstay treatment was effective and safe for the long-term management of RHE.
Collapse
Affiliation(s)
- Amelia Nabatanzi
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Magesa Mafuru
- Department of Pharmacology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Musa Male
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Chunxia Tian
- Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Lingyun Zhang
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Ting Wu
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Shidi Wu
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
| | - Changzheng Huang
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
- Correspondence: Changzheng HuangDepartment of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430022, People’s Republic of ChinaTel +86-13971176116Fax +86-27-85768188 Email
| |
Collapse
|
3
|
Agner T, Elsner P. Hand eczema: epidemiology, prognosis and prevention. J Eur Acad Dermatol Venereol 2019; 34 Suppl 1:4-12. [DOI: 10.1111/jdv.16061] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Accepted: 11/06/2019] [Indexed: 12/27/2022]
Affiliation(s)
- T. Agner
- Department of Dermatology Bispebjerg Hospital University of Copenhagen Copenhagen Denmark
| | - P. Elsner
- Department of Dermatology University Hospital Jena Jena Germany
| |
Collapse
|
4
|
Tauber M, Bérard E, Lourari S, Questel E, Redoules D, Paul C, Simon M. Latent class analysis categorizes chronic hand eczema patients according to skin barrier impairment. J Eur Acad Dermatol Venereol 2019; 34:1529-1535. [DOI: 10.1111/jdv.16083] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Accepted: 10/24/2019] [Indexed: 12/14/2022]
Affiliation(s)
- M. Tauber
- Dermatology and Allergology Department Larrey Hospital Toulouse University Toulouse France
- U1056 UDEAR Purpan Hospital INSERM‐University Paul Sabatier Toulouse France
| | - E. Bérard
- Department of Epidemiology, Health Economics and Public Health UMR1027 INSERM‐ Toulouse University Toulouse University Hospital (CHU) Toulouse France
| | - S. Lourari
- Dermatology and Allergology Department Larrey Hospital Toulouse University Toulouse France
| | - E. Questel
- Pierre Fabre Dermo‐Cosmétique Toulouse France
| | - D. Redoules
- Pierre Fabre Dermo‐Cosmétique Toulouse France
| | - C. Paul
- Dermatology and Allergology Department Larrey Hospital Toulouse University Toulouse France
- U1056 UDEAR Purpan Hospital INSERM‐University Paul Sabatier Toulouse France
| | - M. Simon
- U1056 UDEAR Purpan Hospital INSERM‐University Paul Sabatier Toulouse France
| |
Collapse
|
5
|
Koppes SA, Engebretsen KA, Agner T, Angelova-Fischer I, Berents T, Brandner J, Brans R, Clausen ML, Hummler E, Jakasa I, Jurakić-Tončic R, John SM, Khnykin D, Molin S, Holm JO, Suomela S, Thierse HJ, Kezic S, Martin SF, Thyssen JP. Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis. Contact Dermatitis 2017; 77:1-16. [DOI: 10.1111/cod.12789] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2016] [Revised: 02/07/2017] [Accepted: 02/09/2017] [Indexed: 12/13/2022]
Affiliation(s)
- Sjors A. Koppes
- Department of Coronel Institute of Occupational Health, Academic Medical Center; University of Amsterdam; 1105 AZ Amsterdam The Netherlands
- Department of Dermatology-Allergology; VU University Medical Centre; 081 HV Amsterdam The Netherlands
| | - Kristiane A. Engebretsen
- Department of Dermatology and Allergy, National Allergy Research Centre; Herlev and Gentofte Hospital, University of Copenhagen; 2900 Hellerup Denmark
| | - Tove Agner
- Department of Dermatology; Bispebjerg Hospital, University of Copenhagen; 2400 Copenhagen Denmark
| | | | - Teresa Berents
- Institute of Clinical Medicine; University of Oslo; 0318 Oslo Norway
- Department of Dermatology; Oslo University Hospital; 0424 Oslo Norway
| | - Johanna Brandner
- Department of Dermatology and Venerology; University Hospital Hamburg-Eppendorf; 20246 Hamburg Germany
| | - Richard Brans
- Department of Dermatology, Environmental Medicine and Health Theory; University of Osnabrück; 49076 Osnabrück Germany
| | - Maja-Lisa Clausen
- Department of Dermatology; Bispebjerg Hospital, University of Copenhagen; 2400 Copenhagen Denmark
| | - Edith Hummler
- Department of Pharmacology and Toxicology; University of Lausanne; 1011 Lausanne Switzerland
| | - Ivone Jakasa
- Faculty of Food Technology and Biotechnology, Department of Chemistry and Biochemistry, Laboratory for Analytical Chemistry; University of Zagreb; 10000 Zagreb Croatia
| | - Ružica Jurakić-Tončic
- University Department of Dermatovenereology; Clinical Hospital Zagreb and School of Medicine; 10000 Zagreb Croatia
| | - Swen M. John
- Department of Dermatology, Environmental Medicine and Health Theory; University of Osnabrück; 49076 Osnabrück Germany
| | - Denis Khnykin
- Department of Pathology; Oslo University Hospital - Rikshospitalet; 0424 Oslo Norway
- Centre for Immune Regulation; University of Oslo; 0424 Oslo Norway
| | - Sonja Molin
- Department of Dermatology and Allergology; Ludwig-Maximilians-University; 81377 München Germany
| | - Jan O. Holm
- Institute of Clinical Medicine; University of Oslo; 0318 Oslo Norway
- Department of Dermatology; Oslo University Hospital; 0424 Oslo Norway
| | - Sari Suomela
- Department of Dermatology; Finnish Institute of Occupational Health; 00251 Helsinki Finland
| | - Hermann-Josef Thierse
- Department of Chemicals and Product Safety; German Federal Institute for Risk Assessment; 10589 Berlin Germany
- Laboratory for Immunology & Proteomics, Department of Dermatology and University Medical Centre Mannheim; University of Heidelberg; 68167 Mannheim Germany
| | - Sanja Kezic
- Department of Coronel Institute of Occupational Health, Academic Medical Center; University of Amsterdam; 1105 AZ Amsterdam The Netherlands
| | - Stefan F. Martin
- Department of Dermatology, Allergy Research Group; Medical Centre - University of Freiburg; 79104 Freiburg Germany
| | - Jacob P. Thyssen
- Department of Dermatology and Allergy, National Allergy Research Centre; Herlev and Gentofte Hospital, University of Copenhagen; 2900 Hellerup Denmark
| |
Collapse
|
6
|
The role of epidermal sphingolipids in dermatologic diseases. Lipids Health Dis 2016; 15:13. [PMID: 26786937 PMCID: PMC4717587 DOI: 10.1186/s12944-016-0178-7] [Citation(s) in RCA: 65] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2015] [Accepted: 01/04/2016] [Indexed: 12/15/2022] Open
Abstract
Sphingolipids, a group of lipids containing the sphingoid base, have both structural and biological functions in human epidermis. Ceramides, as a part of extracellular lipids in the stratum corneum, are important elements of the skin barrier and are involved in the prevention of transepidermal water loss. In addition, ceramides regulate such processes as proliferation, differentiation and apoptosis of keratinocytes. Another important sphingolipid, sphingosine-1-phosphate (S1P), inhibits proliferation and induces differentiation of keratinocytes. A recent clinical study of the efficacy and safety of ponesimod (a selective modulator of the S1P receptor 1) suggested that sphingolipid metabolism may become a new target for the pharmacological treatment of psoriasis. The role of sphingolipids in some dermatologic diseases, including psoriasis, atopic dermatitis and ichthyoses was summarized in this article.
Collapse
|